RxDoctor Payments Data

Noah Parker, MD

Otolaryngology · Carmel, INNPI 1215100706

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,469 of the $19,331 with a category attached, or 64.5%. Inspire Medical Systems, Inc. accounts for 92.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $8,446 and has fallen 96.9% since, to $262 in 2025. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,331in general payments, 2019–2025

Across 64 payments — averaging $302.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$18K
  • Medical Device Business Services, Inc.$890
  • Regeneron Healthcare Solutions, Inc.$239
  • Optinose US, Inc.$133
  • Johnson & Johnson$61
  • Acclarent, Inc$42
  • plus $33 from 2 others
$113,856in research payments, 2019–2025

Across 29 payments — averaging $3926.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$114K

What the payments were for

  • Consulting fees$12,46965%
  • Travel & lodging$2,09611%
  • Food & beverage$4,76725%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,331 in reported general payments places this provider in the 95th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$127,171
Medicare patients
226
Services billed
764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole73$943
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen118$653
Famotidine44$369
Esomeprazole Magnesium11$363
Ipratropium Bromide18$298
Cephalexin89$205
Calcitriol28$190
Fluticasone Propionate17$157
Methylprednisolone17$93
Levothyroxine Sodium38$92
Lidocaine Hcl ViscousLidocaine Hcl13$90
Tramadol Hcl13$11

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →